Cambridge Nutritional Sciences plc
CNSL.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$416.41M
Close$
Share Statistics
| Market cap | $416.41 Million |
|---|---|
| Enterprise Value | $411.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | 1.91 |
| Outstanding Shares | 237,950,660 |
Return
| Return on Equity | -35.85% |
|---|---|
| Return on Assets | -24.77% |
| Return on Invested Capital | -43.31% |
Valuation & Multiples
| P/E Ratio | -0.63 |
|---|---|
| PEG | 0.36 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.01 |
| Enterprise Value to EBIT | 0.02 |
| Enterprise Value to Net Income | -116 |
| Total Debt to Enterprise | -0.76 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 8, 2026
EPS Estimate
$-0.00
Average shareholder expectationRevenue Estimate
$3.64 M
Average shareholder expectationNext Earnings Call
Expected Date
November 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$3.06 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cambridge Nutritional Sciences plc
85 employees
CEO: James Cooper Established in 1987 and headquartered in London, UK, Cambridge Nutritional Sciences plc (formerly Omega Diagnostics Group PLC until its name change in September 2023) is a specialist in the development, manufacturing, and supply of medic...